Loading...
| A04206 | Pages: 206 | Apr 2021 | 17957 Views | | |
| Author(s) : Kishor Sherkar, Apoorva Srivastava , Onkar Sumant | Tables: 117 | Charts: 23 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Fertility Services Market
Request Now !The global fertility services market size generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.
COVID-19 outbreak had considerable impact across the world. The fertility services market has been negatively impacted by this pandemic. In addition, most fertility clinics across the globe have stopped undertaking new cases of infertility treatment for the next few months, till the condition seems to be under control.
Fertility services are services provided to support the treatment to cure infertility. These services involve techniques such as in vitro fertilization (IVF), artificial insemination, surrogacy, and others, which help in resolving infertility issues among couples, single mothers, and the LGBT community. Infertility can occur in men or women of child-bearing age. In addition, male infertility is identified majorly as a result of low sperm count or decreased motility of sperms, which may be due to hormonal imbalance. Hence, fertility in men and women requires proper functioning of hypothalamus and pituitary gland. Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 40% of infertile couples, the male partner is responsible for infertility and among them, approximately 85%–90% are treated with drugs or surgery. This is anticipated to drive the fertility services market growth.
Get more information on this report : Request Sample Pages
Technological advancements in assisted reproductive technologies, rise in awareness regarding infertility treatment, and growth in number of fertility clinics are expected to drive the fertility services market growth during the forecast period. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries restrict the growth of the market. Various factors that lead to infertility include problem with sperm or egg production, age, genetic factors, and excessive exposure to some chemicals and toxins. Alcohol consumption, steroid use, surgical removal of one of the testicles due to cancer, and diabetes can also result in low sperm count, thereby leading to infertility problems in men. In women, hormonal disorders, benign growths in uterus, abnormal anatomy of the cervix or uterus, blocked fallopian tubes, stress, chemotherapy, kidney, or sickle cell disease may result in infertility. Furthermore, rise in number of fertility clinics along with growth in awareness about fertility treatments such as sperm/egg donation and in-vitro fertilization escalates the adoption of fertility treatments, thereby propelling the market growth. Moreover, rise in infertility rates is not only due to lifestyle changes but also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the growth of the fertility services market.
The fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Russia and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa).
By fertility services market analysis, the IVF with ICSI segment accounted for half of the market share in fertility services market in 2019. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. Moreover, rapid increase in infertility rate is one of the major factors that drives the growth of the fertility services market.
Get more information on this report : Request Sample Pages
By procedure, the IVF with ICSI segment accounted for the largest market share in 2019. This segment is expected to exhibit a prominent growth rate, attributed to the fact that it has revolutionized male infertility treatment, as it requires smaller number of sperms that are penetrated into the egg with the help of injection technique.
Get more information on this report : Request Sample Pages
Asia-Pacific presents lucrative opportunities for key players operating in the fertility services market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, the fertility services in countries such as India are cheaper as compared to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth in this region. The growth of the fertility services market is supplemented by surge in adoption of fertility procedures and rise in fertility tourism.
Get more information on this report : Request Sample Pages
The key players operating in the global fertility services market include Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited, The Johns Hopkins Health System Corp, Medicover Group, Monash IVF Group, OvaScience Inc., Progyny Inc., and Xytex Cryo International. Other players in the value chain (not included in the report) include Irvine Scientific, INVO Bioscience, LifeGlobal Group, and IVFtech ApS.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Government regulations
3.4.1.U.S.
3.4.2.Europe
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Continuous decline in fertility rates
3.5.1.2.Delayed pregnancies in women
3.5.1.3.Technological advancements with respect to fertility treatment
3.5.2.Restraints
3.5.2.1.High treatment costs of ARTs in developed countries
3.5.2.2.Inadequate reimbursement policies
3.5.3.Opportunity
3.5.3.1.Rise in fertility tourism
3.6.COVID-19 impact on the fertility services market
3.7.Number of fertility service centers
CHAPTER 4:FERTILITY SERVICES MARKET, BY PROCEDURE
4.1.Overview
4.1.1.Market size and forecast
4.2.IVF with ICSI
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.IUI
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.4.IVF without ICSI
4.4.1.Key market trends growth factors, and opportunities
4.4.2.Market size and forecast
4.5.Surrogacy
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast
CHAPTER 5:FERTILITY SERVICES MARKET, BY SERVICE
5.1.Overview
5.1.1.Market size and forecast
5.2.Fresh non-donor
5.2.1.Market size and forecast
5.3.Frozen non-donor
5.3.1.Market size and forecast
5.4.Egg & embryo banking
5.4.1.Market size and forecast
5.5.Fresh donor
5.5.1.Market size and forecast
5.6.Frozen donor
5.6.1.Market size and forecast
CHAPTER 6:FERTILITY SERVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Fertility clinics
6.2.1.Market size and forecast
6.3.Hospitals
6.3.1.Market size and forecast
6.4.Surgical centers
6.4.1.Market size and forecast
6.5.Clinical research institutes
6.5.1.Market size and forecast
CHAPTER 7:FERTILITY SERVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by procedure
7.2.4.Market size and forecast, by service
7.2.5.Market size and forecast, by end user
7.2.5.1.U.S. market size and forecast, by procedure
7.2.5.2.U.S. Market size and forecast, by service
7.2.5.3.U.S. Market size and forecast, by end user
7.2.5.4.Canada size and forecast, by procedure
7.2.5.5.Canada Market size and forecast, by service
7.2.5.6.Canada Market size and forecast, by end user
7.2.5.7.Mexico market size and forecast, by procedure
7.2.5.8.Mexico Market size and forecast, by service
7.2.5.9.Mexico Market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Market size and forecast, by country
7.3.3.Europe Market size and forecast, by procedure
7.3.4.Europe market size and forecast, by service
7.3.5.Europe market size and forecast, by end user
7.3.5.1.Germany market size and forecast, by procedure
7.3.5.2.Germany market size and forecast, by service
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by procedure
7.3.5.5.France market size and forecast, by service
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by procedure
7.3.5.8.UK market size and forecast, by service
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by procedure
7.3.5.11.Italy Market size and forecast, by service
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by procedure
7.3.5.14.Spain Market size and forecast, by service
7.3.5.15.Spain Market size and forecast, by end user
7.3.5.16.Russia market size and forecast, by procedure
7.3.5.17.Russia Market size and forecast, by service
7.3.5.18.Russia market size and forecast, by end user
7.3.5.19.Rest of Europe market size and forecast, by procedure
7.3.5.20.Rest of Europe market size and forecast, by service
7.3.5.21.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by procedure
7.4.4.Asia-Pacific market size and forecast, by service
7.4.5.Asia-Pacific market size and forecast, by end user
7.4.5.1.Japan market size and forecast, by procedure
7.4.5.2.Japan market size and forecast, by service
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.India market size and forecast, by procedure
7.4.5.5.India Market size and forecast, by service
7.4.5.6.India market size and forecast, by end user
7.4.5.7.China market size and forecast, by procedure
7.4.5.8.China Market size and forecast, by service
7.4.5.9.China Market size and forecast, by end user
7.4.5.10.Australia market size and forecast, by procedure
7.4.5.11.Australia Market size and forecast, by service
7.4.5.12.Australia Market size and forecast, by end user
7.4.5.13.South Korea market size and forecast, by procedure
7.4.5.14.South Korea market size and forecast, by service
7.4.5.15.South Korea market size and forecast, by end user
7.4.5.16.Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.17.Rest of Asia-Pacific Market size and forecast, by service
7.4.5.18.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA market size and forecast, by procedure
7.5.4.LAMEA market size and forecast, by service
7.5.5.LAMEA market size and forecast, by end user
7.5.5.1.Latin America market size and forecast, by procedure
7.5.5.2.Latin America market size and forecast, by service
7.5.5.3.Latin America market size and forecast, by end user
7.5.5.4.Middle East market size and forecast
7.5.5.5.Middle East market size and forecast, by service
7.5.5.6.Middle East market size and forecast, by end user
7.5.5.7.Africa market size and forecast
7.5.5.8.Africa market size and forecast, by service
7.5.5.9.Africa market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.APOLLO HOSPITALS ENTERPRISE LTD.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.CARE FERTILITY GROUP LTD.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.CAROLINAS FERTILITY INSTITUTE
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.4.CITY FERTILITY
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.FERTILITY ASSOCIATES LIMITED
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.GENEA LIMITED
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.roduct portfolio
8.7.5.Business performance
8.8.MONASH IVF GROUP LIMITED
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.PROGYNY INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.VIRTUS HEALTH
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW
TABLE 02.GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2019–2027 ($MILLION)
TABLE 03.FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2019–2027 ($MILLION)
TABLE 04.FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2019–2027 ($MILLION)
TABLE 05.FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2019–2027 ($MILLION)
TABLE 06.FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2019–2027 ($MILLION)
TABLE 07.FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 09.FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 10.FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 11.FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2019-2027 ($MILLION)
TABLE 12.FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 13.FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 14.GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 15.FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2019-2027 ($MILLION)
TABLE 16.FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
TABLE 18.FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2019-2027 ($MILLION)
TABLE 19.GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 20.NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 21.NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 22.NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 23.NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 24.U.S. FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 25.U.S. FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 26.U.S. FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.CANADA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 28.CANADA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 29.CANADA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.MEXICO FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 31.MEXICO FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 32.MEXICO FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 35.EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 36.EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 37.GERMANY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 38.GERMANY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 39.GERMANY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.FRANCE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 41.FRANCE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 42.FRANCE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.UK FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 44.UK FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 45.UK FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.ITALY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 47.ITALY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 48.ITALY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 50.SPAIN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 51.SPAIN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.RUSSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 53.RUSSIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 54.RUSSIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.REST OF EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 56.REST OF EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 57.REST OF EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 58.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 59.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 60.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 61.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 63.JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 64.JAPAN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 66.INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 67.INDIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 69.CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 70.CHINA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 72.AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 73.AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 75.SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 76.SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 80.LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 81.LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 82.LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 83.LAMEA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.LATIN AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 85.LATIN AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 86.LATIN AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.MIDDLE EAST FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 88.MIDDLE EAST FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 89.MIDDLE EAST FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.AFRICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 91.AFRICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 92.AFRICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.APOLLO HOSPITALS: COMPANY SNAPSHOT
TABLE 94.APOLLO HOSPITALS: OPERATING SEGMENTS
TABLE 95.APOLLO HOSPITALS: PRODUCT PORTFOLIO
TABLE 96.CARE FERTILITY: COMPANY SNAPSHOT
TABLE 97.CARE FERTILITY: PRODUCT PORTFOLIO
TABLE 98.CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT
TABLE 99.CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO
TABLE 100.CITY FERTILITY: COMPANY SNAPSHOT
TABLE 101.CITY FERTILITY: PRODUCT PORTFOLIO
TABLE 102.FERTILITY ASSOCIATES: COMPANY SNAPSHOT
TABLE 103.FERTILITY ASSOCIATES: OPERATING SEGMENTS
TABLE 104.FERTILITY ASSOCIATES: PRODUCT PORTFOLIO
TABLE 105.GENEA LIMITED: COMPANY SNAPSHOT
TABLE 106.GENEA LIMITED: OPERATING SEGMENTS
TABLE 107.GENEA LIMITED: PRODUCT PORTFOLIO
TABLE 108.MEDICOVER: COMPANY SNAPSHOT
TABLE 109.MEDICOVER: OPERATING SEGMENTS
TABLE 110.MEDICOVER: PRODUCT PORTFOLIO
TABLE 111.MVF: COMPANY SNAPSHOT
TABLE 112.MVF: PRODUCT PORTFOLIO
TABLE 113.PROGYNY: COMPANY SNAPSHOT
TABLE 114.PROGYNY: PRODUCT PORTFOLIO
TABLE 115.VIRTUS HEALTH: COMPANY SNAPSHOT
TABLE 116.VIRTUS HEALTH: OPERATING SEGMENTS
TABLE 117.VIRTUS HEALTH: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.FERTILITY SERVICES MARKET: MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2021
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.HIGH THREAT OF NEW ENTRANT
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.MARKET DYNAMICS
FIGURE 12.APOLLO HOSPITALS: NET SALES, 2018–2020 ($MILLION)
FIGURE 13.APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 14.MEDICOVER: NET SALES, 2018–2020 ($MILLION)
FIGURE 15.MEDICOVER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 16.MEDICOVER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 17.MVF: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.MVF: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 19.PROGYNY: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.PROGYNY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21.VIRTUS HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.VIRTUS HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 23.VIRTUS HEALTH: REVENUE SHARE BY REGION, 2020 (%)
This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs, fertility services refer to different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally.
These services are availed to treat infertility. Different fertility procedures include in vitro fertilization (IVF), intrauterine insemination (IUI), surrogacy, and others. IVF is one of the most widely known fertility services offered by fertility clinics; this treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention.
According to the CXOs, the fertility services market is anticipated to witness considerable growth in future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in assisted reproductive technology (ART) procedures, surge in male infertility, and increased incidence of gamete donations.
Moreover, increase in awareness about IVF and surge in popularity of medical & fertility tourism coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth. However, inadequate reimbursement policies associated with fertility procedures are expected to impede the market growth during the forecast period.
The CXOs further state that growth in interest of single parents as well as same-sex couples in experiencing parenthood through ART and affordable fertility treatment offered in emerging markets such as India are expected to present lucrative opportunities for the market expansion.
This section provides the opinions of the top-level CXOs in the fertility services industry. According to the CXOs, fertility services refer to different assisted reproductive technology procedures undertaken by couples who cannot conceive naturally.
These services are availed to treat infertility. Different fertility procedures include in vitro fertilization (IVF), intrauterine insemination (IUI), surrogacy, and others. IVF is one of the most widely known fertility services offered by fertility clinics; this treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention.
According to the CXOs, the fertility services market is anticipated to witness considerable growth in future, owing to rise in prevalence of infertility, emerging trend of delayed pregnancies among women, technological advancements in assisted reproductive technology (ART) procedures, surge in male infertility, and increased incidence of gamete donations.
Moreover, increase in awareness about IVF and surge in popularity of medical & fertility tourism coupled with advanced ART facilities & treatment options are anticipated to supplement the market growth. However, inadequate reimbursement policies associated with fertility procedures are expected to impede the market growth during the forecast period.
The CXOs further state that growth in interest of single parents as well as same-sex couples in experiencing parenthood through ART and affordable fertility treatment offered in emerging markets such as India are expected to present lucrative opportunities for the market expansion
A. Infertility is a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse
A. Top companies such as Apollo Hospitals Enterprise Ltd., Care Fertility Group, Carolinas Fertility Institute, Genea Limited and others held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI, intrauterine insemination (IUI), surrogacy, and others.
A. The market value of fertility services market in 2027 is $25,709.64 million.
A. The total market value of fertility services market was $20,388.61 million in 2019.
A. The forcast period for fertility services market is 2020 to 2027
A. In procedure segment IVF with ICSI is the most influencing segment. This segment is expected to exhibit a prominent growth rate, owing to some key factors such as higher success rates associated with ICSI-IVF in case of poor sperm morphology, poor sperm motility, low sperm count, and others. In addition, rise in awareness regarding IVF with ICSI also have a positive effect on the market.
A. The base year is 2019 for the fertility services market
A. The major factor that fuels the growth of the global fertility services market includes continuous decline in fertility rates, trend of delayed pregnancy in women, and technological advancements with respect to fertility treatment is expected growth of the market. On the contrary, developing economies and untapped markets are expected to provide lucrative opportunities for the market growth in the future.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries. This is due to the fertility services in countries such as India are cheaper as compare to the developed countries such as the U.S., Canada, and others; thereby, fueling the market growth of fertility services in this region, development in healthcare infrastructure, and rise in number of hospitals & research centers equipped with advanced medical facilities.
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
